News

Akorn Receives FDA Approval for Fluticasone Propionate Nasal Spray USP, 50 mcg per spray (OTC) Published. Apr 18, 2019 4:05pm EDT. LAKE FOREST, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- Akorn ...
LAKE FOREST, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug ...